One simply has to be amazed at the arrogance & hubris of the Dr & his fellow directors at seeking to list with revenue akin to a corner shop. It is simply laughable how little this business has developed both from its inception & during a pandemic. The revenue is all purchased revenue btw. How on earth can the company attract the “sophisticated investors” that they eschewed the ASX for? The company no longer has the luxury of being viewed as a start up. It’s now a tired old dog with tired old tricks.
- Forums
- ASX - By Stock
- GMV
- GMVD - NASDAQ IPO
GMVD - NASDAQ IPO, page-1218
-
- There are more pages in this discussion • 714 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online